Posted August 16, 2023
In this presentation, Dr. Ali Ezzati discusses the topic of artificial intelligence (AI) in clinical research of Alzheimer’s disease (AD), including the challenges in clinical trials for AD, interventions, and how AI can help improve trial design and efficiency of participant recruitment. Dr. Ezzati also shares his perspective on how AI may assist in diagnosis, prognosis, and treatment decisions for AD patients.
